SCHEMBL20083972

SCHEMBL20083972

O=C(Nc1cccc(Cl)c1)c1cccc(CCN2CC(O)C2)c1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.52
▸ RAB9A P51151 3/20 0.52
▸ KMT2A Q03164 2/20 0.51
▸ KCNK3 O14649 2/20 0.50
▸ KCNK9 Q9NPC2 2/20 0.50
▸ MEN1 O00255 1/20 0.49
▸ POLB P06746 1/20 0.49
▸ CASP6 P55212 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ LMNA P02545 1/20 0.48
▸ PTBP1 P26599 1/20 0.48
▸ ACKR3 P25106 1/20 0.48
▸ KDM4E B2RXH2 2/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ MAPT P10636 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ KCNH2 Q12809 1/20 0.47
▸ MCHR1 Q99705 1/20 0.47
▸ MAOB P27338 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21844945 0.89 ACKR3 (0.53) NPC1RAB9AKMT2AKCNK3KCNK9
SCHEMBL19156951 0.87 NPC1 (0.52) NPC1RAB9AKMT2AKCNK3KCNK9
SCHEMBL19157150 0.85 PARP1 (0.51) NPC1RAB9AKMT2AMEN1POLB
SCHEMBL19157226 0.82 HTR1A (0.41) NPC1RAB9AKMT2AMEN1ACKR3
SCHEMBL21844913 0.78 MCHR1 (0.48) NPC1RAB9AKMT2AMEN1LMNA
SCHEMBL21844832 0.77 ACKR3 (0.50) NPC1RAB9AKMT2AKCNK3MEN1
SCHEMBL15276830 0.76 LMNA (0.61) NPC1RAB9AKMT2AMEN1LMNA
SCHEMBL21844944 0.76 HTR1A (0.54) NPC1RAB9AKMT2AKCNK3MEN1
SCHEMBL21844943 0.76 ALDH1A1 (0.54) RAB9AKMT2AKCNK3KCNK9MEN1
SCHEMBL3675463 0.75 KCNK3 (0.84) NPC1RAB9AKMT2AKCNK3KCNK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3312160-A1 HEPATITIS B ANTIVIRAL AGENTS Novira Therapeutics Inc. (US) 2018-04-25 — — EP disclosed
Send feedback